Fundz

Hancock Jaffe Laboratories, Inc. reported raising $194,000 in an initial SEC Form D filing, from an offering of $7.5 Million

PUBLIC · NVNOMar 22, 2017$194K of $7.5M raised

Amount Raised

$194,000

$194,000 sold, per SEC Form D (first sale Mar 22, 2017)

Round Type

Seed

IrvineBiotechnologyHealth CareMedicalMedical Device

Quick answer

enVVeno Medical raised $194,000 in a Seed round, dated March 22, 2017. enVVeno Medical is based in Irvine, California, United States.

How much did enVVeno Medical raise?
enVVeno Medical raised $194,000 in a Seed round on March 22, 2017.
What does enVVeno Medical do?
enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care in..
Where is enVVeno Medical based and how big is it?
enVVeno Medical is based in Irvine, California, United States. Fundz records about 28 employees.
Who are the decision-makers at enVVeno Medical?
Fundz holds 1 contact at enVVeno Medical. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as enVVeno Medical that raised within 45 days of this round, from Fundz verified event records.

  • SPR Therapeutics raised $582K (Seed) on May 5, 2017.
  • Outset Medical raised $76M on May 3, 2017.
  • Grail raised $973M on April 26, 2017.
  • ENvue Medical, Inc. raised $250K on April 3, 2017.
  • ENvue Medical, Inc. raised $100K (Pre-Seed) on April 3, 2017.
  • Dynatronics raised $7.8M on April 3, 2017.

Who to call at enVVeno Medical, and when

A new round usually means enVVeno Medical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day enVVeno Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at enVVeno Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at enVVeno Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

enVVeno Medical

Location

Irvine, California, United States

About

enVVeno Medical (NASDAQ:NVNO) is an Irvine, California-based, late clinical-stage medical device company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care in the treatment of venous disease. The Company’s lead product, the VenoValve®, is a first-in-class implant being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). In healthy patients, valves inside the veins of the leg assist in propelling blood up the leg, and back to the heart and lungs. Affecting approximately 2.4 million people in the United States, CVI occurs when valves inside of the veins of the leg become damaged, resulting in the backwards flow of blood (reflux), blood pooling in the lower leg, increased pressure in the veins of the leg (venous hypertension) and in severe cases, venous ulcers that are difficult to heal and become chronic. Implanted into the femoral vein, the VenoValve is designed to act as a one-way valve, to help restore proper blood flow in the leg. The VenoValve is currently being evaluated in the SAVVE pivotal study.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment enVVeno Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts42 people are listed at enVVeno Medical. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for enVVeno Medical's next move

See what Strategic adds

enVVeno Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.